Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImageneBio (IMA) Current Deferred Revenue (2020 - 2023)

Historic Current Deferred Revenue for ImageneBio (IMA) over the last 4 years, with Q3 2023 value amounting to $659000.0.

  • ImageneBio's Current Deferred Revenue fell 9455.73% to $659000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $659000.0, marking a year-over-year decrease of 9455.73%. This contributed to the annual value of $9.2 million for FY2022, which is 4643.27% down from last year.
  • Latest data reveals that ImageneBio reported Current Deferred Revenue of $659000.0 as of Q3 2023, which was down 9455.73% from $1.8 million recorded in Q2 2023.
  • ImageneBio's Current Deferred Revenue's 5-year high stood at $22.6 million during Q3 2021, with a 5-year trough of $659000.0 in Q3 2023.
  • Over the past 4 years, ImageneBio's median Current Deferred Revenue value was $16.9 million (recorded in 2021), while the average stood at $13.9 million.
  • Per our database at Business Quant, ImageneBio's Current Deferred Revenue tumbled by 1707.88% in 2021 and then tumbled by 9455.73% in 2023.
  • Over the past 4 years, ImageneBio's Current Deferred Revenue (Quarter) stood at $20.6 million in 2020, then fell by 17.08% to $17.1 million in 2021, then crashed by 46.43% to $9.2 million in 2022, then crashed by 92.81% to $659000.0 in 2023.
  • Its Current Deferred Revenue was $659000.0 in Q3 2023, compared to $1.8 million in Q2 2023 and $3.8 million in Q1 2023.